MUC5AC concentrations in lung lavage fluids are associated with acute lung injury after cardiac surgery

Judith van Paassen1, Pieter S Hiemstra2, Abraham C van der Linden2

  • 1Department of Intensive Care, Leiden University Medical Center, Albinusdreef 2, Leiden, B4-57, 2333 ZA, the Netherlands. j.van_paassen@lumc.nl.

Respiratory Research
|March 8, 2024
PubMed

Insights

Increased mucins MUC5AC and MUC5B in the lungs after cardiac surgery are linked to acute lung injury and longer intensive care unit (ICU) stays. Early detection of MUC5AC in mini-bronchoalveolar lavage may predict complications.

Area of Science:

  • Pulmonary medicine
  • Critical care medicine
  • Biomarker research

Background:

  • Acute lung injury (ALI) and adult respiratory distress syndrome (ARDS) are significant complications following cardiac surgery.
  • Elevated expression of mucins MUC5AC and MUC5B has been observed in ALI.
  • This study investigates perioperative changes in mucins and other biomarkers in mini-bronchoalveolar lavage (minBAL) after cardiac surgery.

Discussion:

  • Perioperative analysis of minBAL fluid revealed increased levels of MUC5AC, MUC5B, IL-8, human neutrophil elastase, and neutrophils post-surgery.
  • A significant negative association was found between perioperative MUC5AC change and postoperative P/F ratio (p=0.018).
  • A positive association was observed between perioperative MUC5AC change and intensive care unit (ICU) stay (p=0.027).

Key Insights:

  • Early perioperative increase in MUC5AC in minBAL is associated with poorer lung function (lower P/F ratio) after cardiac surgery.
  • Elevated MUC5AC levels correlate with prolonged ICU admission, suggesting a role in post-cardiac surgery lung injury.
  • These findings highlight MUC5AC as a potential early biomarker for lung complications in cardiac surgery patients.

Outlook:

  • Further research could explore therapeutic strategies targeting MUC5AC to mitigate lung injury post-cardiac surgery.
  • Investigating the precise mechanisms linking MUC5AC to lung injury and prolonged ICU stay is warranted.
  • Validation of MUC5AC as a predictive biomarker in larger cohorts could improve patient management and outcomes.